BANK VONTOBEL/CALL/CVS HEALTH/84/0.1/20.12.24 Share Price

Warrant

DE000VD3SQN4

Market Closed - Boerse Frankfurt Warrants 11:22:38 26/06/2024 pm IST
0.037 EUR -5.13% Intraday chart for BANK VONTOBEL/CALL/CVS HEALTH/84/0.1/20.12.24
Current month+2.78%
1 month+60.87%
Date Price Change
26/24/26 0.037 -5.13%
25/24/25 0.039 -15.22%
24/24/24 0.046 +2.22%
21/24/21 0.045 -4.26%
20/24/20 0.047 -4.08%

Real-time Boerse Frankfurt Warrants

Last update June 26, 2024 at 11:22 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD3SQN
ISINDE000VD3SQN4
Date issued 09/04/2024
Strike 84 $
Maturity 20/12/2024 (177 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.233
Lowest since issue 0.019
Spread 0.01
Spread %21.28%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
60.63 USD
Average target price
69.1 USD
Spread / Average Target
+13.96%
Consensus